Technology | Clinical Decision Support | February 14, 2018

FDA Clears First AI-Powered Clinical Decision Support Software for Stroke

Viz.AI Contact application uses artificial intelligence algorithm to analyze CT images for stroke indicators; approval paves way for future computer-aided triage software devices

FDA Clears First AI-Powered Clinical Decision Support Software for Stroke

February 14, 2018 — The U.S. Food and Drug Administration (FDA) announced marketing clearance for Viz.AI’s Contact application, the first artificial intelligence (AI)-based clinical decision support (CDS) solution cleared for sale in the U.S. Viz.AI Contact is designed to analyze computed tomography (CT) results that may notify providers of a potential stroke in their patients.

A stroke occurs if the flow of oxygen-rich blood to a portion of the brain is blocked, also known as an occlusion. According to the Centers for Disease Control and Prevention, stroke is the fifth leading cause of death in the U.S. and is a major cause of serious disability for adults. About 795,000 people in the U.S. have a stroke each year.

“Strokes can cause serious and irreversible damage to patients. The software device could benefit patients by notifying a specialist earlier thereby decreasing the time to treatment. Faster treatment may lessen the extent or progression of a stroke,” said Robert Ochs, Ph.D., acting deputy director for radiological health, Office of In Vitro Diagnostics and Radiological Health in the FDA’s Center for Devices and Radiological Health.

The Viz.AI Contact application is a computer-aided triage software that uses an artificial intelligence algorithm to analyze images for indicators associated with a stroke. These types of algorithms can assist providers in identifying the most appropriate treatment plan for a patient’s disease or condition. The FDA is currently creating a regulatory framework for these products that encourages developers to create, adapt and expand the functionalities of their software to aid providers in diagnosing and treating diseases and conditions.

The Viz.AI Contact application is designed to analyze CT images of the brain and send a text notification to a neurovascular specialist if a suspected large vessel occlusion (LVO) has been identified. The algorithm will automatically notify the specialist during the same time the first-line provider is conducting a standard review of the images, potentially involving the specialist sooner than the usual standard of care in which patients wait for a radiologist to review CT images and notify a neurovascular specialist. The notification can be sent to a mobile device, such as a smartphone or tablet, but the specialist still needs to review the images on a clinical workstation.

The Viz.AI Contact application is intended to be used by neurovascular specialists, such as vascular neurologists, neuro-interventional specialists or other professionals with similar training. The application is limited to analysis of imaging data and should not be used as a replacement of a full patient evaluation or solely relied upon to make or confirm a diagnosis.

The company submitted a retrospective study of 300 CT images that assessed the independent performance of the image analysis algorithm and notification functionality of the Viz.AI Contact application against the performance of two trained neuro-radiologists for the detection of large vessel blockages in the brain. Real-world evidence was used with a clinical study to demonstrate that the application could notify a neurovascular specialist sooner in cases where a blockage was suspected. The Viz.ai LVO Stroke Platform obtained an AUC of 0.91, identifying LVOs and alerting the relevant specialist with 90 percent sensitivity and specificity, and a median scan to notification time of under 6 minutes. In over 95 percent of cases, the automatic notifications demonstrated faster notification of the specialist, saving between 6 and 206 minutes, with an average time saving of 52 minutes.

The Viz.AI Contact application was reviewed through the De Novo premarket review pathway, a regulatory pathway for some new types of medical devices that are low to moderate risk and have no legally marketed predicate device to base a determination of substantial equivalence. This action also creates a new regulatory classification, which means that subsequent computer-aided triage software devices with the same medical imaging intended use may go through the FDA’s premarket 510(k) notification process, whereby devices can obtain marketing authorization by demonstrating substantial equivalence to a predicate device.

For more information: www.viz.ai

Related Artificial Intelligence Content

Technology Report: Artificial Intelligence 2017

Why AI By Any Name Is Sweet For Radiology

VIDEO: Examples of How Artificial Intelligence Will Improve Medical Imaging

VIDEO: Deep Learning is Key Technology Trend at RSNA 2017

Machine Learning Concerns Discussed at RSNA/AAPM Symposium

 

Related Content

News | PACS Accessories | February 22, 2018
The RamSoft team will showcase radiology solutions to help users cut costs and save time at the 2018 Healthcare...
Mirada Medical Releases DLCExpert for Radiotherapy Treatment Planning
Technology | Treatment Planning | February 22, 2018
February 22, 2018 — U.K.-based medical imaging software provider Mirada Medical has released DLCExpert, the first com
ECR 2018 Spotlights Artificial Intelligence and Current Radiology Trends
News | Interventional Radiology | February 21, 2018
The European Congress of Radiology (ECR) announced the theme of its 2018 annual meeting, Feb. 28-March 4 in Vienna...
Sponsored Content | Videos | Flat Panel Displays | February 21, 2018
This 5 megapixel, high-brightness color monitor has the high-definition display necessary for breast imaging.
Axumin PET Agent Added to NCCN Guidelines for Suspected Recurrent Prostate Cancer
News | PET Imaging | February 21, 2018
Blue Earth Diagnostics announced that Axumin (fluciclovine F 18) injection has been added to the National Comprehensive...
Barco Highlights Imaging Workflow Compliance at HIMSS18
News | Flat Panel Displays | February 21, 2018
Barco will showcase its full line of radiology and mammography display systems with online quality assurance (QA)...
Aidoc Introduces AI Solution for Whole-Body CT Scan Analysis
News | Artificial Intelligence | February 20, 2018
Deep learning startup company Aidoc announced what it calls the world’s first and only comprehensive, full-body...
Lumedx Demonstrates Advanced Analytics at HIMSS18
News | Information Technology | February 20, 2018
February 20, 2018 – LUMEDX Corporation, a top cardiovascular data intelligence company, will show off the latest in a
Logicalis White Paper Aims to Optimize Every Healthcare IT Dollar
News | Information Technology | February 20, 2018
February 20, 2018 – Digital transformation is happening in all industries, and it will happen in healthcare whether h
Agfa Introduces Improved Engage Suite for Integrated Care
News | Patient Engagement | February 16, 2018
At the 2018 Healthcare and Information Management Systems Society annual meeting (HIMSS18), Agfa HealthCare will...
Overlay Init